New advances in Traditional Chinese Medicine interventions for epilepsy: where are we and what do we know?

被引:0
|
作者
Sun, Minjuan [1 ]
Qiu, Xiaoyun [1 ]
Yuan, Zhijian [1 ]
Xu, Cenglin [1 ]
Chen, Zhong [1 ]
机构
[1] Zhejiang Chinese Med Univ, Sch Clin Med 5, Huzhou Cent Hosp, Coll Pharmaceut Sci,Key Lab Neuropharmacol & Trans, Hangzhou, Zhejiang, Peoples R China
来源
CHINESE MEDICINE | 2025年 / 20卷 / 01期
基金
中国国家自然科学基金;
关键词
Epilepsy; Traditional Chinese Medicine; Herbal medicine; Prescription; Acupuncture; Epileptic comorbidities; STATUS EPILEPTICUS; TANSHINONE IIA; ANTICONVULSANT ACTIVITY; UNCARIA-RHYNCHOPHYLLA; COGNITIVE IMPAIRMENT; CURCUMA-LONGA; MODEL; SEIZURES; HIPPOCAMPAL; DEPRESSION;
D O I
10.1186/s13020-025-01088-z
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Epilepsy, one of the most common neurological diseases, affects more than 70 million people worldwide. Anti-seizure drugs targeting membrane ion channels or GABAergic neurotransmission are the first choices for controlling seizures, whereas the high incidence of pharmacoresistance and adverse effects largely restrict the availability of current anti-seizure drugs (ASDs). Traditional Chinese Medicine (TCM) has shown historical evidence-based therapeutic effects for neurological diseases including epilepsy. But until the late 1990s, great efforts in both clinical and experimental fields advanced TCM interventions for epilepsy from evidence-based practices to more systematic neuropharmacological significance, and show new lights on preferable management of epilepsy in the last decade. This review summarized the advances of applying TCM interventions (ranging from herbal medicines and their active ingredients to other strategies such as acupuncture) for epilepsy, followed by associated mechanism theories. The therapeutic potential of TCM interventions for epilepsy as well as its comorbidities turns from somehow debatable to hopeful. Finally, some prospects and directions were proposed to drive further clinical translational research. The future directions of TCM should aim at not only deriving specific anti-epileptic molecules but also illustrating more precise mechanisms with the assistance of advanced multifaceted experimental tools.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Ketogenic Diet and Epilepsy: What We Know So Far
    Meira, Isabella D'Andrea
    Romao, Tayla Taynan
    Pires do Prado, Henrique Jannuzzelli
    Kruger, Lia Theophilo
    Paiva Pires, Maria Elisa
    da Conceicao, Priscila Oliveira
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [42] A systematic review of correlates of depression among older Chinese and Korean immigrants: what we know and do not know
    Guo, Man
    Stensland, Meredith
    AGING & MENTAL HEALTH, 2018, 22 (12) : 1535 - 1547
  • [43] Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next?
    Bender, Bruce G.
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (02) : 132 - 137
  • [44] Work and mental health: what do we know and how can we intervene?
    Rugulies, Reiner
    Aust, Birgit
    SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2019, 45 (06) : 529 - 532
  • [45] Measurement Artifacts in the Assessment of Counterproductive Work Behavior and Organizational Citizenship Behavior: Do We Know What We Think We Know?
    Spector, Paul E.
    Bauer, Jeremy A.
    Fox, Suzy
    JOURNAL OF APPLIED PSYCHOLOGY, 2010, 95 (04) : 781 - 790
  • [46] Credit risk and the business cycle: What do we know?
    Chortareas, Georgios
    Magkonis, Georgios
    Zekente, Kalliopi-Maria
    INTERNATIONAL REVIEW OF FINANCIAL ANALYSIS, 2020, 67
  • [47] How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do?
    Macleod, John
    Hickman, Matthew
    ADDICTION, 2010, 105 (08) : 1326 - 1330
  • [48] Learnings in developmental and epileptic encephalopathies: what do we know?
    Perinelli, Martina Giorgia
    Riva, Antonella
    Amadori, Elisabetta
    Follo, Roberta
    Striano, Pasquale
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (01) : 45 - 57
  • [49] What Do We Really Know About Employee Engagement?
    Saks, Alan M.
    Gruman, Jamie A.
    HUMAN RESOURCE DEVELOPMENT QUARTERLY, 2014, 25 (02) : 155 - 182
  • [50] Suicide among Adolescents in Jamaica: What Do We Know?
    Holder-Nevins, D.
    James, K.
    Bridgelal-Nagassar, R.
    Bailey, A.
    Thompson, E.
    Eldemire, H.
    Sewell, C.
    Abel, W. D.
    WEST INDIAN MEDICAL JOURNAL, 2012, 61 (05) : 516 - 520